Repros Therapeutics Reports Fourth Quarter And Year End 2016 Financial Results Post author:Sam Post published:March 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab July 30, 2017 Cambridge-Based Biotech Scoops Up $46.7 Million in Funding Round October 4, 2017 Ophthotech's Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study August 13, 2017